Skip to main content
Top
Published in: Journal of Neurology 2/2021

01-02-2021 | Subdural Hematoma | Original Communication

Hemorrhagic reversible cerebral vasoconstriction syndrome: A retrospective observational study

Authors: Smit D. Patel, Karan Topiwala, Vasu Saini, Neel Patel, Mubashir Pervez, Fawaz Al-Mufti, Ameer E. Hassan, Priyank Khandelwal, Robert M. Starke

Published in: Journal of Neurology | Issue 2/2021

Login to get access

Abstract

Background and purpose

Reversible cerebral vasoconstriction syndrome (RCVS) is characterized by recurrent thunderclap headaches associated with segmental vasoconstriction of cerebral arteries, which may result in intracranial hemorrhage (ICH). There is a lack of contemporary data available regarding the ICH burden in RCVS cohort. Our aim of the study is to assess the ICH burden, associated risk factors, and discharge outcome of ICH in patients with RCVS.

Methods

All patients diagnosed with RCVS in the 2016 Nationwide Readmission Database were identified using ICD-10 code after excluding patients with the concurrent diagnosis of primary angiitis. ICH was defined as both intraparenchymal (IPH), subarachnoid hemorrhage (SAH), and subdural hematoma (SDH). Categorical and continuous variables were assessed by the Rao-Scott Chi-square test and the Wilcoxon signed-rank sum test respectively. We used a multivariable survey-weighted logistic model to determine the association between ICH and RCVS patient-level characteristics.

Findings

A total of 799 patients were identified with RCVS. Total hospitalization of ICH was 43.4% [(95% CI 36.4–50.4%); (n = 346)] including SAH 35.9% [(95% CI 29.7–42.1%); (n = 287)], IPH 13.1% [(95% CI 9.5–16.7%); (n = 105)] and SDH 3.6% [(95% CI 1.5–5.6%); (n = 28)]. Patients with hemorrhagic RCVS (H-RCVS) had a mean age (years ± SE) of 47.4 ± 1.1 vs. 45.5 ± 1.2 years in R-RCVS (p = 0.247); and were predominantly female (84.0% vs. 68.8%; p = 0.001); with longer inpatient stays (10.9 vs. 6.8 days; p = 0.016); and a higher inpatient cost ($44,300 vs. $21,350; p < 0.001). On multivariable analyses, higher odds of ICH were female sex 2.57 (95% CI 1.45–4.55; p = 0.001), middle age-group (45–64 years) 1.87 (CI: 1.11–3.15; p = 0.018) and older age group (> 64 years) 3.72 (CI: 1.15–12.03; p = 0.029). About 67.0% of all H-RCVS patients were discharged home, with no observed inpatient mortality.

Interpretation

Intracerebral hemorrhage is the most common vascular complication in hospitalized RCVS patients, resulting in longer hospitalizations with more invasive procedures and higher healthcare expenditure. However, overall outcomes are excellent regardless of types of ICH, with no inpatient mortality observed in patients with hemorrhagic RCVS. Female sex and middle to older age-group are associated with higher odds of ICH.
Appendix
Available only for authorised users
Literature
1.
go back to reference Miller TR, Shivashankar R, Mossa-Basha M, Gandhi D (2015) Reversible cerebral vasoconstriction syndrome, part 1: epidemiology, pathogenesis, and clinical course. AJNR Am J Neuroradiol 36:1392–1399CrossRef Miller TR, Shivashankar R, Mossa-Basha M, Gandhi D (2015) Reversible cerebral vasoconstriction syndrome, part 1: epidemiology, pathogenesis, and clinical course. AJNR Am J Neuroradiol 36:1392–1399CrossRef
2.
go back to reference Ducros A, Boukobza M, Porcher R, Sarov M, Valade D, Bousser MG (2007) The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain 130:3091–3101CrossRef Ducros A, Boukobza M, Porcher R, Sarov M, Valade D, Bousser MG (2007) The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain 130:3091–3101CrossRef
3.
go back to reference Armstrong FS, Hayes GJ (1961) Segmental cerebral arterial constriction associated with pheochromocytoma. J Neurosurg 18:843CrossRef Armstrong FS, Hayes GJ (1961) Segmental cerebral arterial constriction associated with pheochromocytoma. J Neurosurg 18:843CrossRef
4.
go back to reference Call GK, Fleming MC, Sealfon S, Levine H, Kistler JP, Fisher CM (1988) Reversible cerebral segmental vasoconstriction. Stroke 19:1159–1170CrossRef Call GK, Fleming MC, Sealfon S, Levine H, Kistler JP, Fisher CM (1988) Reversible cerebral segmental vasoconstriction. Stroke 19:1159–1170CrossRef
5.
go back to reference Ducros A (2012) Reversible cerebral vasoconstriction syndrome. Lancet Neurol 11:906–917CrossRef Ducros A (2012) Reversible cerebral vasoconstriction syndrome. Lancet Neurol 11:906–917CrossRef
6.
go back to reference Topcuoglu MA, Singhal AB (2016) Hemorrhagic reversible cerebral vasoconstriction syndrome: features and mechanisms. Stroke 47:1742–1747CrossRef Topcuoglu MA, Singhal AB (2016) Hemorrhagic reversible cerebral vasoconstriction syndrome: features and mechanisms. Stroke 47:1742–1747CrossRef
7.
go back to reference Choi HA, Lee MJ, Choi H, Chung CS (2018) Characteristics and demographics of reversible cerebral vasoconstriction syndrome: a large prospective series of Korean patients. Cephalalgia 38:765–775CrossRef Choi HA, Lee MJ, Choi H, Chung CS (2018) Characteristics and demographics of reversible cerebral vasoconstriction syndrome: a large prospective series of Korean patients. Cephalalgia 38:765–775CrossRef
8.
go back to reference Ducros A, Fiedler U, Porcher R, Boukobza M, Stapf C, Bousser MG (2010) Hemorrhagic manifestations of reversible cerebral vasoconstriction syndrome: frequency, features, and risk factors. Stroke 41:2505–2511CrossRef Ducros A, Fiedler U, Porcher R, Boukobza M, Stapf C, Bousser MG (2010) Hemorrhagic manifestations of reversible cerebral vasoconstriction syndrome: frequency, features, and risk factors. Stroke 41:2505–2511CrossRef
12.
go back to reference Hassan AE, Chaudhry SA, Grigoryan M, Tekle WG, Qureshi AI (2012) National trends in utilization and outcomes of endovascular treatment of acute ischemic stroke patients in the mechanical thrombectomy era. Stroke 43:3012–3017CrossRef Hassan AE, Chaudhry SA, Grigoryan M, Tekle WG, Qureshi AI (2012) National trends in utilization and outcomes of endovascular treatment of acute ischemic stroke patients in the mechanical thrombectomy era. Stroke 43:3012–3017CrossRef
14.
go back to reference Calabrese LH, Dodick DW, Schwedt TJ, Singhal AB (2007) Narrative review: reversible cerebral vasoconstriction syndromes. Ann Intern Med 146:34–44CrossRef Calabrese LH, Dodick DW, Schwedt TJ, Singhal AB (2007) Narrative review: reversible cerebral vasoconstriction syndromes. Ann Intern Med 146:34–44CrossRef
15.
go back to reference Topcuoglu MA, McKee KE, Singhal AB (2016) Gender and hormonal influences in reversible cerebral vasoconstriction syndrome. Eur Stroke Journal 1:199–204CrossRef Topcuoglu MA, McKee KE, Singhal AB (2016) Gender and hormonal influences in reversible cerebral vasoconstriction syndrome. Eur Stroke Journal 1:199–204CrossRef
16.
go back to reference Krause DN, Duckles SP, Pelligrino DA (2006) Influence of sex steroid hormones on cerebrovascular function. J Appl Physiol 101:1252–1261CrossRef Krause DN, Duckles SP, Pelligrino DA (2006) Influence of sex steroid hormones on cerebrovascular function. J Appl Physiol 101:1252–1261CrossRef
17.
go back to reference Sattar A, Manousakis G, Jensen MB (2010) Systematic review of reversible cerebral vasoconstriction syndrome. Expert Rev Cardiovasc Ther 8:1417–1421CrossRef Sattar A, Manousakis G, Jensen MB (2010) Systematic review of reversible cerebral vasoconstriction syndrome. Expert Rev Cardiovasc Ther 8:1417–1421CrossRef
18.
go back to reference An SJ, Kim TJ, Yoon B-W (2017) Epidemiology, risk factors, and clinical features of intracerebral hemorrhage: an update. J Stroke 19:3–10CrossRef An SJ, Kim TJ, Yoon B-W (2017) Epidemiology, risk factors, and clinical features of intracerebral hemorrhage: an update. J Stroke 19:3–10CrossRef
19.
go back to reference Boitet R, de Gaalon S, Duflos C et al (2020) Long-term outcomes after reversible cerebral vasoconstriction syndrome. Stroke 51:670–673CrossRef Boitet R, de Gaalon S, Duflos C et al (2020) Long-term outcomes after reversible cerebral vasoconstriction syndrome. Stroke 51:670–673CrossRef
Metadata
Title
Hemorrhagic reversible cerebral vasoconstriction syndrome: A retrospective observational study
Authors
Smit D. Patel
Karan Topiwala
Vasu Saini
Neel Patel
Mubashir Pervez
Fawaz Al-Mufti
Ameer E. Hassan
Priyank Khandelwal
Robert M. Starke
Publication date
01-02-2021
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 2/2021
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-020-10193-y

Other articles of this Issue 2/2021

Journal of Neurology 2/2021 Go to the issue